Annual Total Liabilities
$2.61 M
-$3.54 M-57.57%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual total liabilities is $2.61 million, with the most recent change of -$3.54 million (-57.57%) on December 1, 2023.
- During the last 3 years, BRTX annual total liabilities has fallen by -$3.07 million (-54.08%).
- BRTX annual total liabilities is now -81.69% below its all-time high of $14.24 million, reached on December 31, 2019.
Performance
BRTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.58 M
-$738.30 K-13.88%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly total liabilities is $4.58 million, with the most recent change of -$738.30 thousand (-13.88%) on September 1, 2024.
- Over the past year, BRTX quarterly total liabilities has increased by +$3.61 million (+369.90%).
- BRTX quarterly total liabilities is now -75.78% below its all-time high of $18.91 million, reached on March 31, 2020.
Performance
BRTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BRTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.6% | +369.9% |
| 3 y3 years | -54.1% | +434.9% |
| 5 y5 years | -73.5% | +434.9% |
BRTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.6% | +204.4% | -25.4% | +671.4% |
| 5 y | 5-year | -81.7% | +204.4% | -75.8% | +671.4% |
| alltime | all time | -81.7% | +204.4% | -75.8% | +671.4% |
BioRestorative Therapies Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.58 M(-13.9%) |
| Jun 2024 | - | $5.32 M(+54.3%) |
| Mar 2024 | - | $3.45 M(+32.2%) |
| Dec 2023 | $2.61 M(-57.6%) | $2.61 M(+167.4%) |
| Sep 2023 | - | $975.00 K(+8.8%) |
| Jun 2023 | - | $896.40 K(+50.9%) |
| Mar 2023 | - | $593.90 K(-90.3%) |
| Dec 2022 | $6.14 M(+617.4%) | $6.14 M(+570.9%) |
| Sep 2022 | - | $915.90 K(+7.0%) |
| Jun 2022 | - | $855.80 K(+12.3%) |
| Mar 2022 | - | $762.20 K(-11.0%) |
| Dec 2021 | $856.50 K(-84.9%) | $856.50 K(-87.9%) |
| Sep 2021 | - | $7.05 M(+5.4%) |
| Jun 2021 | - | $6.69 M(+4.7%) |
| Mar 2021 | - | $6.40 M(+12.6%) |
| Dec 2020 | $5.68 M(-60.1%) | $5.68 M(-65.6%) |
| Sep 2020 | - | $16.52 M(+2.9%) |
| Jun 2020 | - | $16.05 M(-15.1%) |
| Mar 2020 | - | $18.91 M(+32.8%) |
| Dec 2019 | $14.24 M(+44.8%) | $14.24 M(+2.6%) |
| Sep 2019 | - | $13.89 M(+22.1%) |
| Jun 2019 | - | $11.37 M(+23.1%) |
| Mar 2019 | - | $9.24 M(-6.1%) |
| Dec 2018 | $9.83 M(+14.4%) | $9.83 M(-3.5%) |
| Sep 2018 | - | $10.19 M(-8.0%) |
| Jun 2018 | - | $11.07 M(+24.2%) |
| Mar 2018 | - | $8.91 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $8.60 M(+30.6%) | $8.60 M(+6.0%) |
| Sep 2017 | - | $8.11 M(+13.6%) |
| Jun 2017 | - | $7.14 M(+15.1%) |
| Mar 2017 | - | $6.20 M(-5.7%) |
| Dec 2016 | $6.58 M(+11.1%) | $6.58 M(+8.1%) |
| Sep 2016 | - | $6.09 M(-1.8%) |
| Jun 2016 | - | $6.20 M(+10.9%) |
| Mar 2016 | - | $5.59 M(-5.7%) |
| Dec 2015 | $5.93 M(-30.9%) | $5.93 M(-0.0%) |
| Sep 2015 | - | $5.93 M(+19.7%) |
| Jun 2015 | - | $4.95 M(-46.5%) |
| Mar 2015 | - | $9.25 M(+7.8%) |
| Dec 2014 | $8.58 M(+6.3%) | $8.58 M(+6.5%) |
| Sep 2014 | - | $8.05 M(-3.4%) |
| Jun 2014 | - | $8.33 M(+1.2%) |
| Mar 2014 | - | $8.24 M(+2.1%) |
| Dec 2013 | $8.07 M(+25.9%) | $8.07 M(+2.7%) |
| Sep 2013 | - | $7.86 M(+12.5%) |
| Jun 2013 | - | $6.99 M(+5.6%) |
| Mar 2013 | - | $6.61 M(+3.2%) |
| Dec 2012 | $6.41 M(+64.0%) | $6.41 M(-1.0%) |
| Sep 2012 | - | $6.48 M(+15.6%) |
| Jun 2012 | - | $5.60 M(+26.9%) |
| Mar 2012 | - | $4.41 M(+13.0%) |
| Dec 2011 | $3.91 M(+222.2%) | $3.91 M(+4.3%) |
| Sep 2011 | - | $3.75 M(+209.0%) |
| Dec 2010 | $1.21 M | $1.21 M |
FAQ
- What is BioRestorative Therapies annual total liabilities?
- What is the all time high annual total liabilities for BioRestorative Therapies?
- What is BioRestorative Therapies annual total liabilities year-on-year change?
- What is BioRestorative Therapies quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly total liabilities year-on-year change?
What is BioRestorative Therapies annual total liabilities?
The current annual total liabilities of BRTX is $2.61 M
What is the all time high annual total liabilities for BioRestorative Therapies?
BioRestorative Therapies all-time high annual total liabilities is $14.24 M
What is BioRestorative Therapies annual total liabilities year-on-year change?
Over the past year, BRTX annual total liabilities has changed by -$3.54 M (-57.57%)
What is BioRestorative Therapies quarterly total liabilities?
The current quarterly total liabilities of BRTX is $4.58 M
What is the all time high quarterly total liabilities for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly total liabilities is $18.91 M
What is BioRestorative Therapies quarterly total liabilities year-on-year change?
Over the past year, BRTX quarterly total liabilities has changed by +$3.61 M (+369.90%)